Semax

peptideresearch peptide

Research chemical — not an approved drug or dietary supplement

This compound is sold for research and is not FDA-approved for human use or as a dietary supplement. Human evidence is limited; purity and dosing of consumer products are unverified. The data below is an evidence review for education only — talk to a clinician before considering it.

At a glance

Best for
Not established — investigational
Main caution
Not FDA-approved; limited independent human evidence and unregulated research-grade purity
Evidence strength: Preclinical plus limited regional (Russian) clinical use; no approved human use in the U.S.

What is it

Semax is a synthetic peptide based on a fragment of adrenocorticotropic hormone (ACTH 4-10), developed in Russia and proposed to have neuroprotective and nootropic effects by modulating BDNF and other neurotrophic signaling. It is registered and used as a medication in Russia (e.g., as a nasal drop) for certain neurological indications, but it is not FDA-approved in the United States and has not been validated in large independent controlled trials outside Russian-language literature. Evidence is largely preclinical and limited regional clinical use; it is not a dietary supplement and is sold in the West only 'for research use only.'

Is it worth it for you?

Probably skip if…

  • You expect an FDA-approved or independently validated nootropic — it is neither
  • You would buy from 'research use only' vendors with no purity or sterility controls
  • You are not prepared for unknown long-term safety outside limited regional use
  • You are uncomfortable that most efficacy data come from non-replicated, single-region literature
  • You want to avoid legal gray areas around importing unapproved drugs

Safety

Common side effects

Reported in limited use: generally described as mild; possible nasal irritation with intranasal use. Not well characterized in independent trials

Serious risks

  • Unregulated purity, sterility, and dosing of research-grade product
  • Unknown long-term neurological and hormonal effects (ACTH-fragment origin)
  • Lack of independent safety monitoring or validated dosing
  • Possible contamination in non-pharmaceutical research-grade material

Who should avoid it

  • Anyone using it without direct medical supervision
  • Pregnancy and breastfeeding
  • People with psychiatric or neurological conditions (without supervision)
  • Anyone relying on it in place of evaluated medical treatment

Pregnancy & breastfeeding

Avoid — no safety data.

Choosing a product

Be skeptical of

  • 'Proven' cognitive-enhancement or neuroprotection claims for the general public
  • Vendors selling 'for research use only' product for human use
  • Implying U.S. approval or equivalence to evaluated nootropic medications

Track Semax with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: This compound is not approved by the FDA for human use and is not a dietary supplement. This page is an educational review of available research — much of it preclinical or early-stage — not a recommendation to use it. Consumer product quality is unregulated. Consult a qualified clinician.